- Home
- REVG vs BSX Comparison
REVG vs BSX Comparison
Compare REVG & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REVG
- BSX
- Stock Information
- Founded
- REVG 2008
- BSX 1979
- Country
- REVG United States
- BSX United States
- Employees
- REVG N/A
- BSX N/A
- Industry
- REVG Auto Manufacturing
- BSX Medical/Dental Instruments
- Sector
- REVG Consumer Discretionary
- BSX Health Care
- Exchange
- REVG Nasdaq
- BSX Nasdaq
- Market Cap
- REVG N/A
- BSX 138.5B
- IPO Year
- REVG 2017
- BSX 1992
- Fundamental
- Price
- REVG $32.29
- BSX $101.91
- Analyst Decision
- REVG Hold
- BSX Strong Buy
- Analyst Count
- REVG 4
- BSX 23
- Target Price
- REVG $33.75
- BSX $110.57
- AVG Volume (30 Days)
- REVG 903.1K
- BSX 10.5M
- Earning Date
- REVG 06-04-2025
- BSX 04-23-2025
- Dividend Yield
- REVG 0.74%
- BSX N/A
- EPS Growth
- REVG N/A
- BSX 15.23
- EPS
- REVG 1.77
- BSX 1.37
- Revenue
- REVG $2,319,300,000.00
- BSX $17,554,000,000.00
- Revenue This Year
- REVG $2.51
- BSX $15.77
- Revenue Next Year
- REVG $6.97
- BSX $10.33
- P/E Ratio
- REVG $18.28
- BSX $74.36
- Revenue Growth
- REVG N/A
- BSX 19.36
- 52 Week Low
- REVG $20.86
- BSX $70.97
- 52 Week High
- REVG $36.00
- BSX $107.17
- Technical
- Relative Strength Index (RSI)
- REVG 55.79
- BSX 59.77
- Support Level
- REVG $28.49
- BSX $92.70
- Resistance Level
- REVG $32.36
- BSX $102.37
- Average True Range (ATR)
- REVG 1.54
- BSX 3.73
- MACD
- REVG 0.17
- BSX 0.98
- Stochastic Oscillator
- REVG 94.89
- BSX 97.19
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.